Loading…

Osteoarthritis in the cat: 2. How should it be managed and treated?

Practical relevance Osteoarthritis (OA) is very common in the cat and in many cases is associated with significant long-term pain, which limits mobility and activity, and severely compromises the animal’s quality of life. Clinical challenges The treatment of chronic arthritic pain is a major challen...

Full description

Saved in:
Bibliographic Details
Published in:Journal of feline medicine and surgery 2012, Vol.14 (1), p.76-84
Main Authors: Bennett, David, Zainal Ariffin, Siti Mariam bt, Johnston, Pamela
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c369t-d76553f9a4cd6e79b404d8543a51c3ea6596ae53e6b4a583b50959c71015328a3
container_end_page 84
container_issue 1
container_start_page 76
container_title Journal of feline medicine and surgery
container_volume 14
creator Bennett, David
Zainal Ariffin, Siti Mariam bt
Johnston, Pamela
description Practical relevance Osteoarthritis (OA) is very common in the cat and in many cases is associated with significant long-term pain, which limits mobility and activity, and severely compromises the animal’s quality of life. Clinical challenges The treatment of chronic arthritic pain is a major challenge and many analgesic drugs used in other species are not licensed, not available or not tested for use in the cat. Many older cats with painful OA have some degree of chronic kidney disease (CKD) and many clinicians are reluctant to use non-steroidal anti-inflammatory drugs (NSAIDs) in these animals because of the potential for nephrotoxicity. Evidence base There are several publications that show that meloxicam is an effective NSAID for the cat and can be used long-term. It is easy to administer and there is published evidence that meloxicam can actually slow the progression of CKD in this species. Many other drugs are used to treat chronic pain in the cat but there is no documented evidence of their efficacy in OA. Unlike the dog, there is limited evidence for the effectiveness of omega-3 fatty acid-rich diets in managing feline OA and further work is required. There is no published data as yet for the usefulness or otherwise of nutraceuticals (glucosamine and chondroitin) in managing feline OA; studies in the authors’ clinic suggest some pain-relieving effect. Research into environmental enrichment as a way of improving quality of life in cats with painful OA is lacking, but it is an approach worth using where possible. Modifications to the environment (eg, provision of comfortable bedding and ramps) are also important.
doi_str_mv 10.1177/1098612X11432829
format article
fullrecord <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11148914</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1098612X11432829</sage_id><sourcerecordid>916521593</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-d76553f9a4cd6e79b404d8543a51c3ea6596ae53e6b4a583b50959c71015328a3</originalsourceid><addsrcrecordid>eNp9kUtLxDAURoMoPkb3rjQ7Vx3zaNrGjcjgCwQXKrgLt-2dmUin0SRV_PdmGBV14SqB79wvyQkh-5yNOS_LY850VXDxyHkuRSX0GtnmSopMlIqtp32Ks2W-RXZCeGKMaanFJtkSQuSlFOU2mdyGiA58nHsbbaC2p3GOtIF4QsWYXrk3GuZu6FpqI62RLqCHGbYU-pZGjxCxPd0lG1PoAu59riPycHF-P7nKbm4vrydnN1kjCx2ztiyUklMNedMWWOo6Z3lbqVyC4o1EKJQuAJXEos5BVbJWTCvdlJwt31SBHJHTVe_zUC-wbbCPHjrz7O0C_LtxYM3vpLdzM3Ovhic_lU6ORuTos8G7lwFDNAsbGuw66NENwWheKMGVlolkK7LxLgSP0-9jODNL9-av-zRy8PN63wNfshOQrYCQFJonN_g-6fqv8HDFT8EZmHkbzMOdYDxPH8mTFSk_AAvik7Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>916521593</pqid></control><display><type>article</type><title>Osteoarthritis in the cat: 2. How should it be managed and treated?</title><source>SAGE Journals</source><creator>Bennett, David ; Zainal Ariffin, Siti Mariam bt ; Johnston, Pamela</creator><creatorcontrib>Bennett, David ; Zainal Ariffin, Siti Mariam bt ; Johnston, Pamela</creatorcontrib><description>Practical relevance Osteoarthritis (OA) is very common in the cat and in many cases is associated with significant long-term pain, which limits mobility and activity, and severely compromises the animal’s quality of life. Clinical challenges The treatment of chronic arthritic pain is a major challenge and many analgesic drugs used in other species are not licensed, not available or not tested for use in the cat. Many older cats with painful OA have some degree of chronic kidney disease (CKD) and many clinicians are reluctant to use non-steroidal anti-inflammatory drugs (NSAIDs) in these animals because of the potential for nephrotoxicity. Evidence base There are several publications that show that meloxicam is an effective NSAID for the cat and can be used long-term. It is easy to administer and there is published evidence that meloxicam can actually slow the progression of CKD in this species. Many other drugs are used to treat chronic pain in the cat but there is no documented evidence of their efficacy in OA. Unlike the dog, there is limited evidence for the effectiveness of omega-3 fatty acid-rich diets in managing feline OA and further work is required. There is no published data as yet for the usefulness or otherwise of nutraceuticals (glucosamine and chondroitin) in managing feline OA; studies in the authors’ clinic suggest some pain-relieving effect. Research into environmental enrichment as a way of improving quality of life in cats with painful OA is lacking, but it is an approach worth using where possible. Modifications to the environment (eg, provision of comfortable bedding and ramps) are also important.</description><identifier>ISSN: 1098-612X</identifier><identifier>ISSN: 1532-2750</identifier><identifier>EISSN: 1532-2750</identifier><identifier>DOI: 10.1177/1098612X11432829</identifier><identifier>PMID: 22247327</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>analgesic effect ; analgesics ; Animals ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Cat Diseases - therapy ; Cats ; Clinical Reviews ; diet ; dogs ; environmental enrichment ; Evidence-Based Medicine ; kidneys ; Meloxicam ; nephrotoxicity ; nonsteroidal anti-inflammatory agents ; osteoarthritis ; Osteoarthritis - therapy ; Osteoarthritis - veterinary ; pain ; quality of life ; Thiazines - therapeutic use ; Thiazoles - therapeutic use</subject><ispartof>Journal of feline medicine and surgery, 2012, Vol.14 (1), p.76-84</ispartof><rights>International Society of Feline Medicine and American Association of Feline Practitioners 2012</rights><rights>International Society of Feline Medicine and American Association of Feline Practitioners 2012 2012 International Society of Feline Medicine and American Association of Feline Practitioners</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c369t-d76553f9a4cd6e79b404d8543a51c3ea6596ae53e6b4a583b50959c71015328a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11148914/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11148914/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,21966,27853,27923,27924,27925,44945,45333,53791,53793</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/1098612X11432829?utm_source=summon&amp;utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22247327$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bennett, David</creatorcontrib><creatorcontrib>Zainal Ariffin, Siti Mariam bt</creatorcontrib><creatorcontrib>Johnston, Pamela</creatorcontrib><title>Osteoarthritis in the cat: 2. How should it be managed and treated?</title><title>Journal of feline medicine and surgery</title><addtitle>J Feline Med Surg</addtitle><description>Practical relevance Osteoarthritis (OA) is very common in the cat and in many cases is associated with significant long-term pain, which limits mobility and activity, and severely compromises the animal’s quality of life. Clinical challenges The treatment of chronic arthritic pain is a major challenge and many analgesic drugs used in other species are not licensed, not available or not tested for use in the cat. Many older cats with painful OA have some degree of chronic kidney disease (CKD) and many clinicians are reluctant to use non-steroidal anti-inflammatory drugs (NSAIDs) in these animals because of the potential for nephrotoxicity. Evidence base There are several publications that show that meloxicam is an effective NSAID for the cat and can be used long-term. It is easy to administer and there is published evidence that meloxicam can actually slow the progression of CKD in this species. Many other drugs are used to treat chronic pain in the cat but there is no documented evidence of their efficacy in OA. Unlike the dog, there is limited evidence for the effectiveness of omega-3 fatty acid-rich diets in managing feline OA and further work is required. There is no published data as yet for the usefulness or otherwise of nutraceuticals (glucosamine and chondroitin) in managing feline OA; studies in the authors’ clinic suggest some pain-relieving effect. Research into environmental enrichment as a way of improving quality of life in cats with painful OA is lacking, but it is an approach worth using where possible. Modifications to the environment (eg, provision of comfortable bedding and ramps) are also important.</description><subject>analgesic effect</subject><subject>analgesics</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Cat Diseases - therapy</subject><subject>Cats</subject><subject>Clinical Reviews</subject><subject>diet</subject><subject>dogs</subject><subject>environmental enrichment</subject><subject>Evidence-Based Medicine</subject><subject>kidneys</subject><subject>Meloxicam</subject><subject>nephrotoxicity</subject><subject>nonsteroidal anti-inflammatory agents</subject><subject>osteoarthritis</subject><subject>Osteoarthritis - therapy</subject><subject>Osteoarthritis - veterinary</subject><subject>pain</subject><subject>quality of life</subject><subject>Thiazines - therapeutic use</subject><subject>Thiazoles - therapeutic use</subject><issn>1098-612X</issn><issn>1532-2750</issn><issn>1532-2750</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kUtLxDAURoMoPkb3rjQ7Vx3zaNrGjcjgCwQXKrgLt-2dmUin0SRV_PdmGBV14SqB79wvyQkh-5yNOS_LY850VXDxyHkuRSX0GtnmSopMlIqtp32Ks2W-RXZCeGKMaanFJtkSQuSlFOU2mdyGiA58nHsbbaC2p3GOtIF4QsWYXrk3GuZu6FpqI62RLqCHGbYU-pZGjxCxPd0lG1PoAu59riPycHF-P7nKbm4vrydnN1kjCx2ztiyUklMNedMWWOo6Z3lbqVyC4o1EKJQuAJXEos5BVbJWTCvdlJwt31SBHJHTVe_zUC-wbbCPHjrz7O0C_LtxYM3vpLdzM3Ovhic_lU6ORuTos8G7lwFDNAsbGuw66NENwWheKMGVlolkK7LxLgSP0-9jODNL9-av-zRy8PN63wNfshOQrYCQFJonN_g-6fqv8HDFT8EZmHkbzMOdYDxPH8mTFSk_AAvik7Y</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>Bennett, David</creator><creator>Zainal Ariffin, Siti Mariam bt</creator><creator>Johnston, Pamela</creator><general>SAGE Publications</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2012</creationdate><title>Osteoarthritis in the cat: 2. How should it be managed and treated?</title><author>Bennett, David ; Zainal Ariffin, Siti Mariam bt ; Johnston, Pamela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-d76553f9a4cd6e79b404d8543a51c3ea6596ae53e6b4a583b50959c71015328a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>analgesic effect</topic><topic>analgesics</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Cat Diseases - therapy</topic><topic>Cats</topic><topic>Clinical Reviews</topic><topic>diet</topic><topic>dogs</topic><topic>environmental enrichment</topic><topic>Evidence-Based Medicine</topic><topic>kidneys</topic><topic>Meloxicam</topic><topic>nephrotoxicity</topic><topic>nonsteroidal anti-inflammatory agents</topic><topic>osteoarthritis</topic><topic>Osteoarthritis - therapy</topic><topic>Osteoarthritis - veterinary</topic><topic>pain</topic><topic>quality of life</topic><topic>Thiazines - therapeutic use</topic><topic>Thiazoles - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bennett, David</creatorcontrib><creatorcontrib>Zainal Ariffin, Siti Mariam bt</creatorcontrib><creatorcontrib>Johnston, Pamela</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of feline medicine and surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Bennett, David</au><au>Zainal Ariffin, Siti Mariam bt</au><au>Johnston, Pamela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Osteoarthritis in the cat: 2. How should it be managed and treated?</atitle><jtitle>Journal of feline medicine and surgery</jtitle><addtitle>J Feline Med Surg</addtitle><date>2012</date><risdate>2012</risdate><volume>14</volume><issue>1</issue><spage>76</spage><epage>84</epage><pages>76-84</pages><issn>1098-612X</issn><issn>1532-2750</issn><eissn>1532-2750</eissn><abstract>Practical relevance Osteoarthritis (OA) is very common in the cat and in many cases is associated with significant long-term pain, which limits mobility and activity, and severely compromises the animal’s quality of life. Clinical challenges The treatment of chronic arthritic pain is a major challenge and many analgesic drugs used in other species are not licensed, not available or not tested for use in the cat. Many older cats with painful OA have some degree of chronic kidney disease (CKD) and many clinicians are reluctant to use non-steroidal anti-inflammatory drugs (NSAIDs) in these animals because of the potential for nephrotoxicity. Evidence base There are several publications that show that meloxicam is an effective NSAID for the cat and can be used long-term. It is easy to administer and there is published evidence that meloxicam can actually slow the progression of CKD in this species. Many other drugs are used to treat chronic pain in the cat but there is no documented evidence of their efficacy in OA. Unlike the dog, there is limited evidence for the effectiveness of omega-3 fatty acid-rich diets in managing feline OA and further work is required. There is no published data as yet for the usefulness or otherwise of nutraceuticals (glucosamine and chondroitin) in managing feline OA; studies in the authors’ clinic suggest some pain-relieving effect. Research into environmental enrichment as a way of improving quality of life in cats with painful OA is lacking, but it is an approach worth using where possible. Modifications to the environment (eg, provision of comfortable bedding and ramps) are also important.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>22247327</pmid><doi>10.1177/1098612X11432829</doi><tpages>9</tpages></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1098-612X
ispartof Journal of feline medicine and surgery, 2012, Vol.14 (1), p.76-84
issn 1098-612X
1532-2750
1532-2750
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11148914
source SAGE Journals
subjects analgesic effect
analgesics
Animals
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Cat Diseases - therapy
Cats
Clinical Reviews
diet
dogs
environmental enrichment
Evidence-Based Medicine
kidneys
Meloxicam
nephrotoxicity
nonsteroidal anti-inflammatory agents
osteoarthritis
Osteoarthritis - therapy
Osteoarthritis - veterinary
pain
quality of life
Thiazines - therapeutic use
Thiazoles - therapeutic use
title Osteoarthritis in the cat: 2. How should it be managed and treated?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A39%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Osteoarthritis%20in%20the%20cat:%202.%20How%20should%20it%20be%20managed%20and%20treated?&rft.jtitle=Journal%20of%20feline%20medicine%20and%20surgery&rft.au=Bennett,%20David&rft.date=2012&rft.volume=14&rft.issue=1&rft.spage=76&rft.epage=84&rft.pages=76-84&rft.issn=1098-612X&rft.eissn=1532-2750&rft_id=info:doi/10.1177/1098612X11432829&rft_dat=%3Cproquest_AFRWT%3E916521593%3C/proquest_AFRWT%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c369t-d76553f9a4cd6e79b404d8543a51c3ea6596ae53e6b4a583b50959c71015328a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=916521593&rft_id=info:pmid/22247327&rft_sage_id=10.1177_1098612X11432829&rfr_iscdi=true